The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
The development of new research methods for the valuation of EQ-5D-5L
Open accessAbstract
The EQ-5D is arguably now the most well-known and commonly used generic measure of health status internationally. It is available in 169 languages, with applications in clinical, cost-effectiveness and population health studies, as well as (more recently) its routine use by health-care systems. A key feature of the EQ-5D is the availability of ‘value sets’ to weight the EQ-5D health states reported by patients and populations. These value sets provide, for each of the 243 health states described by the EQ-5D, a value (‘utility’) on a scale anchored at 1 (full health) and 0 (dead), reflecting the preferences of the general public, which can be used to estimate quality-adjusted life years (QALYs). These value sets are widely used in the analysis of EQ-5D data and inform a wide range of resource allocation decisions. Value sets for the 3-level version of the EQ-5D (3L) are available
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9903-x · Cited by 9,795 · cited 1×
“One of the recent developments was a five-level version, the EQ-5D-5L [3].”
Background(1997) · doi:10.1097/00005650-199711000-00002 · Cited by 4,544
Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets
van Hout, B., Janssen, M. F., Feng, Y.-S., Kohlmann, T., Busschbach, J., Golicki, D., Lloyd, A., Scalone, L., Kind, P., & Pickard, A. S. (2012) · Value in Health · doi:10.1016/j.jval.2012.02.008 · Cited by 2,153
A Program of Methodological Research to Arrive at the New International EQ-5D-5L Valuation Protocol
Oppe, M., Devlin, N. J., van Hout, B., Krabbe, P. F. M., & de Charro, F. (2014) · Value in Health · doi:10.1016/j.jval.2014.04.002 · Cited by 428
Self-citationNICE Guide to the Methods of Technology Appraisal: Pharmaceutical Industry Perspective
Earnshaw, J., & Lewis, G. (2008) · PharmacoEconomics · doi:10.2165/00019053-200826090-00002 · Cited by 226
Devlin, N. J., Tsuchiya, A., Buckingham, K., & Tilling, C. (2010) · Health Economics · doi:10.1002/hec.1596 · Cited by 145
Self-citation
Cited by
Dutch Tariff for the Five-Level Version of EQ-5D
M. Versteegh, M., M. Vermeulen, K., M. A. A. Evers, S., de Wit, G. A., Prenger, R., & A. Stolk, E. (2016) · Value in Health · doi:10.1016/j.jval.2016.01.003 · Cited by 1,113
German Value Set for the EQ-5D-5L
Ludwig, K., Graf von der Schulenburg, J.-M., & Greiner, W. (2018) · PharmacoEconomics · doi:10.1007/s40273-018-0615-8 · Cited by 587
Methods for Analysing and Reporting EQ-5D Data
Devlin, N., Parkin, D., & Janssen, B. (2020) · Springer eBooks · doi:10.1007/978-3-030-47622-9 · Cited by 371
Self-citationStolk, E., Ludwig, K., Rand, K., van Hout, B., & Ramos-Goñi, J. M. (2019) · Value in Health · doi:10.1016/j.jval.2018.05.010 · Cited by 362
Buchholz, I., Janssen, M. F., Kohlmann, T., & Feng, Y.-S. (2018) · PharmacoEconomics · doi:10.1007/s40273-018-0642-5 · Cited by 354
Metadata
- Authors
- Devlin, N. J., & Krabbe, P. F. M.
- Venue
- The European Journal of Health Economics
- Published
- 2013-07
- Volume
- 14
- Issue
- S1
- Pages
- 1-3
- ISSN
- 1439-3972 (ISSN-L)
- 1618-7598
- 1618-7601
- OpenAlex
- W2031535915
- Cited by
- 261
- References
- 6
- FWCI
- 45.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The development of new research methods for the valuation of EQ-5D-5L. https://app.cochat.ai/papers/10.1007/s10198-013-0502-3
- The paper
- Devlin, N. J., & Krabbe, P. F. M. (2013). The development of new research methods for the valuation of EQ-5D-5L. The European Journal of Health Economics. https://doi.org/10.1007/s10198-013-0502-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.